Italy drops pharma bidding probe

Italy’s Competition Authority has ended its investigation into a temporary bidding arrangement between Kedrion and Grifols, finding the agreement did not infringe competition law even though each pharmaceutical company could have bid for the contract individually.

Unlock unlimited access to all Global Competition Review content